19 Documents disponibles écrits par cet auteur
2-(Methylamino)-1-(2-methylphenyl)propan-1-one (2-methylmethcathinone, 2-MMC) is a synthetic cathinone monitored by the EUDA as a new psychoactive substance through the European Union Early Warning System. Based on potential public health risks,[...]
1-(4-Bromophenyl)-2-(methylamino)propan-1-one (4-bromomethcathinone, 4-BMC) is a synthetic cathinone monitored by the EUDA as a new psychoactive substance through the European Union Early Warning System. Based on potential public health risks, a[...]
Cannabis remains the most widely used illicit drug in Europe. Our updated miniguide explores key health and social risks associated with its use, alongside evidence-based approaches to prevention, treatment and harm reduction across Europe. This[...]
Illicit drug production in the European Union is a persistent and evolving phenomenon, encompassing a wide range of substances and production methods. The EUDA supports EU-level understanding of illicit drug production by bringing together infor[...]
This technical protocol outlines the key steps and considerations to be taken when deciding whether and how to set up a survey for monitoring DRID, related risk factors and preventive interventions among people who inject drugs (PWID). [Editor's[...]
"EU Drug Market: MDMA" describes the European MDMA market from production to trafficking, distribution and use. It details the materials, processes and players involved at different stages and levels of the market. The module takes a threat asse[...]
On this page you can explore data from the hospitals participating in the European Drug Emergencies Network (Euro-DEN - Euro-DEN Plus) project. Since 2013, the project has been collecting data on acute drug toxicity presentations in an expandin[...]
FRANÇAIS : Les changements rapides sur le marché européen des drogues créent de nouveaux risques pour la santé et la sécurité. Ils mettent à l'épreuve la capacité de la région à y faire face. Cette mise en garde émane de l'Agence de l'Union eur[...]
This data factsheet presents insights from the European Web Survey on Drugs 2024. It provides an overview of key data from 61 732 individuals aged 18 or older who use drugs and live in one of 24 EU countries or Norway. The survey was conducted a[...]
This page provides answers to the questions most often asked about drug overdose deaths in Europe. Also known as 'drug-related deaths' or more specifically 'drug-induced deaths', they are deaths directly attributable to the use of illicit drugs.[...]
These pages answer the questions most often asked about gender and drugs, with a focus on the situation in Europe. Men are more likely than women to use substances, including illicit drugs. There are notable differences in patterns of use and p[...]
This page provides an overview of key issues related to the provision of harm reduction equipment for high-risk drug use, including service delivery, guidance and evidence, and considerations for implementation. It also considers implications fo[...]
This publication presents a consolidated EU-level assessment of ketamine trafficking and related emerging risks, developed under Operational Action 1.5 of the 2024-2025 EMPACT Synthetic Drugs and New Psychoactive Substances action plan. Drawing [...]
2-(Ethylamino)-1-phenylpentan-1-one (N-ethylnorpentedrone, NEP) is a synthetic cathinone monitored by the EUDA as a new psychoactive substance through the European Union Early Warning System. Based on potential public health risks, an initial re[...]
Réaliser une enquête en milieu carcéral est une tâche difficile. L'environnement spécifique dans lequel l'enquête est menée, ainsi que le profil des personnes potentiellement interrogées, posent des difficultés dans le déroulement du travail de [...]
Historique
